4893 items matching your search terms.

FOXFIRE-SIRFLOX-FOXFIRE global prospective randomised studies of first-line selectiveinternal radiotherapy in patients with liver metastases from colorectal cancer: KRAS mutation and tumour site analysis

Wasan, H. Sharma, R. Heinemann, V. Sharma, N. Taieb, J. Ricke, J. Peeters, G. Findlay, M. Virdee, P. S. Love, S. Moschandreas, J. Dutton, P. Gebski, V. Gray, A. Price, D. Bower, G. Montazeri, A. Gibbs, P. Van Hazel, G.

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Wasan, H. S. Gibbs, P. Sharma, N. K. Taieb, J. Heinemann, V. Ricke, J. Peeters, M. Findlay, M. Weaver, A. Mills, J. Wilson, C. Adams, R. Francis, A. Moschandreas, J. Virdee, P. S. Dutton, P. Love, S. Gebski, V. Gray, A. Foxfire trial investigators Sirflox trial investigators F. OXFIRE-Global trial investigators van Hazel, G. Sharma, R. A.
LANCET ONCOLOGY, 2017     DOI:10.1016/S1470-2045(17)30457-6

Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of melanoma

Watts, C. G. Cust, A. E. Menzies, S. W. Mann, G. J. Morton, R. L.
JOURNAL OF CLINICAL ONCOLOGY, 2017     DOI:10.1200/JCO.2016.68.4308

Clinical features associated with individuals at higher risk of melanoma: a population-based study

Watts, C. G. Madronio, C. Morton, R. L. Goumas, C. Armstrong, B. K. Curtin, A. Menzies, S. W. Mann, G. J. Thompson, J. F. Cust, A. E.
JAMA DERMATOL, 2017     DOI:10.1001/jamadermatol.2016.3327

Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: a population-based study in New South Wales, Australia

Watts, C. G. Madronio, C. M. Morton, R. L. Goumas, C. Armstrong, B. K. Curtin, A. Menzies, S. W. Mann, G. J. Thompson, J. F. Cust, A. E.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017     DOI:10.1111/ajd.12530

Chronic kidney disease

Webster, A. C. Nagler, E. V. Morton, R. L. Masson, P.
LANCET, 2017     DOI:10.1016/S0140-6736(16)32064-5

A randomized trial of egg introduction from 4 months of age in infants at risk for egg allergy

Wei-Liang Tan, J. Valerio, C. Barnes, E. H. Turner, P. J. Van Asperen, P. A. Kakakios, A. M. Campbell, D. E. Beating Egg Allergy Trial Study, Group
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017     DOI:10.1016/j.jaci.2016.08.035

GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale

Welch, V. A. Akl, E. A. Guyatt, G. Pottie, K. Eslava-Schmalbach, J. Ansari, M. T. de Beer, H. Briel, M. Dans, T. Dans, I. Hultcrantz, M. Jull, J. Katikireddi, S. V. Meerpohl, J. Morton, R. Mosdol, A. Petkovic, J. Schunemann, H. J. Sharaf, R. N. Singh, J. A. Stanev, R. Tonia, T. Tristan, M. Vitols, S. Watine, J. Tugwell, P.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017     DOI:10.1016/j.jclinepi.2017.01.014

GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence

Welch, V. A. Akl, E. A. Pottie, K. Ansari, M. T. Briel, M. Christensen, R. Dans, A. Dans, L. Eslava-Schmalbach, J. Guyatt, G. Hultcrantz, M. Jull, J. Katikireddi, S. V. Lang, E. Matovinovic, E. Meerpohl, J. J. Morton, R. L. Mosdol, A. Murad, M. H. Petkovic, J. Schunemann, H. Sharaf, R. Shea, B. Singh, J. A. Sola, I. Stanev, R. Stein, A. Thabaneii, L. Tonia, T. Tristan, M. Vitols, S. Watine, J. Tugwell, P.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017     DOI:10.1016/j.jclinepi.2017.01.015

Age as a predictive and prognostic factor for targeted therapy treatment in metastatic chemorefractory colorectal cancer: an analysis of NCIC CTG CO.17 and CO.20

Wells, C. Siu, L.L. Shapiro, J.D. Tu, D. Jonker, D.J. Karapetis, C.. Simes, J. Liu, G. Price, T.J. Tebbutt, T.J. O'Callaghan, C.J.

Sentinel-lymph-node-based management or routine axillary clearance? Five-year outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and incidence of true lymphedema

Wetzig, N. Gill, P. G. Espinoza, D. Mister, R. Stockler, M. R. Gebski, V. J. Ung, O. A. Campbell, I. Simes, J.
ANNALS OF SURGICAL ONCOLOGY, 2017     DOI:10.1245/s10434-016-5669-2

Combination of palbociclib and radiotherapy for glioblastoma

Whittaker, S. Madani, D. Joshi, S. Chung, S. A. Johns, T. Day, B. Khasraw, M. McDonald, K. L.
CELL DEATH DISCOV, 2017     DOI:10.1038/cddiscovery.2017.33

The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study

Wiedmann, M. K. H. Brunborg, C. Di Ieva, A. Lindemann, K. Johannesen, T. B. Vatten, L. Helseth, E. Zwart, J. A.
NEURO ONCOL, 2017     DOI:10.1093/neuonc/now272

Randomised phase III trial of enzalutamide in androgen deprivation therapy with radiation therapy for clinically localised, high risk, or node-positive prostate cancer: ENZARAD (ANZUP 1303)

Williams, S. Davis, I.D. Sweeney, C. Stockler, M.R. Martin, A.J. Hague, W. Coskinas, X. Yip, S. Tu, E. Lawrence, N.J. McDermott, R. Kelly, P.J. Deignan, O. Hughes, S. Fonteyne V. Tombal, B.L. Nguyen, P.L. Australian and New Zealand Urogenital and Prostate Cancer Trials Group,

Questionnaires used to assess barriers of clinical guideline use among physicians are not comprehensive, reliable, or valid: a scoping review

Willson, M. L. Vernooij, R. W. M. Gagliardi, A. R. Guidelines International Network Implementation Working, Group
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017     DOI:10.1016/j.jclinepi.2016.12.012